对于纤维化间质性肺疾病患者而言，夜间低氧血症这一“无声威胁”仍未得到解决。
The "silent threat" of nocturnal hypoxia remains unresolved for patients with fibrotic interstitial lung diseases.
作者信息
Suzuki Atsushi
机构信息
Department of Medicine, Division of Pulmonary and Critical Care, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
出版信息
ERJ Open Res. 2024 Feb 12;10(1). doi: 10.1183/23120541.01017-2023. eCollection 2024 Jan.
Abstract
摘要
https://bit.ly/3RNzNVu. （链接无法直接翻译，保留原文）
相似文献
1
The "silent threat" of nocturnal hypoxia remains unresolved for patients with fibrotic interstitial lung diseases.对于纤维化间质性肺疾病患者而言，夜间低氧血症这一“无声威胁”仍未得到解决。
ERJ Open Res. 2024 Feb 12;10(1). doi: 10.1183/23120541.01017-2023. eCollection 2024 Jan.
2
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey.纤维化间质性肺疾病的皮质类固醇治疗：一项改良德尔菲调查
ERJ Open Res. 2024 Oct 7;10(5). doi: 10.1183/23120541.00561-2024. eCollection 2024 Sep.
3
Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect.纤维化间质性肺疾病患者报告的生活质量：自我管理能力和情感的新评估
ERJ Open Res. 2021 Mar 8;7(1). doi: 10.1183/23120541.00011-2021. eCollection 2021 Jan.
4
Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.进展性肺纤维化间质性肺病患者夜间低氧血症与症状进展和死亡率相关。
Chest. 2023 Nov;164(5):1232-1242. doi: 10.1016/j.chest.2023.05.013. Epub 2023 May 13.
5
The relationship between perceived and performance fatigability in severe fibrotic interstitial lung disease: a prospective, cross-sectional study.重度纤维化间质性肺疾病中感知疲劳与运动表现疲劳之间的关系：一项前瞻性横断面研究。
ERJ Open Res. 2023 May 9;9(3). doi: 10.1183/23120541.00726-2022. eCollection 2023 May.
6
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new.间质性肺异常是类风湿关节炎间质性肺病进展的危险因素：有哪些新情况。
Breathe (Sheff). 2020 Dec;16(4):200223. doi: 10.1183/20734735.0223-2020.
7
Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on.成人表面活性剂相关间质性肺疾病的肺移植结局：前行的首个证据
ERJ Open Res. 2023 Nov 20;9(6). doi: 10.1183/23120541.00646-2023. eCollection 2023 Nov.
8
Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification.纤维化性间质性肺疾病高分辨率 CT 扫描表现及更新分类的影像学综述
Chest. 2024 Apr;165(4):908-923. doi: 10.1016/j.chest.2023.11.037. Epub 2024 Jan 1.
9
Elevated nocturnal desaturation index predicts mortality in interstitial lung disease.夜间低氧饱和度指数升高可预测间质性肺疾病患者的死亡率。
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):41-50.
10
Identification of a Novel HIF-1α-αβ Integrin-NET Axis in Fibrotic Interstitial Lung Disease.鉴定纤维化性间质性肺疾病中新型的 HIF-1α-αβ 整合素-NET 轴。
Front Immunol. 2020 Oct 15;11:2190. doi: 10.3389/fimmu.2020.02190. eCollection 2020.
本文引用的文献
1
Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality.间质性肺疾病的夜间血氧饱和度下降：与肺血管病变及死亡率的关联
ERJ Open Res. 2024 Feb 12;10(1). doi: 10.1183/23120541.00740-2023. eCollection 2024 Jan.
2
Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.进展性肺纤维化间质性肺病患者夜间低氧血症与症状进展和死亡率相关。
Chest. 2023 Nov;164(5):1232-1242. doi: 10.1016/j.chest.2023.05.013. Epub 2023 May 13.
3
Nocturnal hypoxaemia in interstitial lung disease: a systematic review.间质性肺疾病的夜间低氧血症：系统评价。
Thorax. 2021 Dec;76(12):1200-1208. doi: 10.1136/thoraxjnl-2020-216749. Epub 2021 Apr 29.
4
Comparing the effects of supplemental oxygen therapy and continuous positive airway pressure on patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials.比较补充氧疗法和持续气道正压通气对阻塞性睡眠呼吸暂停患者的影响：一项随机对照试验的荟萃分析。
Sleep Breath. 2021 Dec;25(4):2231-2240. doi: 10.1007/s11325-020-02245-4. Epub 2021 Jan 7.
5
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.慢性肺部疾病成人家庭氧疗。美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Nov 15;202(10):e121-e141. doi: 10.1164/rccm.202009-3608ST.
6
Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment.特发性肺纤维化伴或不伴阻塞性睡眠呼吸暂停患者的临床特征、临床结局差异及 PAP 治疗的影响。
J Clin Sleep Med. 2021 Mar 1;17(3):533-544. doi: 10.5664/jcsm.8932.
7
The circadian clock protein REVERBα inhibits pulmonary fibrosis development.昼夜节律钟蛋白 REVERBα 抑制肺纤维化的发展。
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1139-1147. doi: 10.1073/pnas.1912109117. Epub 2019 Dec 26.
8
Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline.成人阻塞性睡眠呼吸暂停治疗：美国睡眠医学学会临床实践指南。
J Clin Sleep Med. 2019 Feb 15;15(2):335-343. doi: 10.5664/jcsm.7640.
9
Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing.特发性肺纤维化患者的生活质量：睡眠呼吸障碍的影响。
Respir Med. 2019 Feb;147:51-57. doi: 10.1016/j.rmed.2018.12.018. Epub 2019 Jan 10.
10
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.门诊吸氧对肺纤维化疾病患者生活质量的影响（AmbOx）：一项前瞻性、开放标签、混合方法、交叉随机对照试验。
Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.
Zotero 插件